Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients

Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients

Immunosuppressive molecules are valuable prognostic biomarkers across different cancer types. Leukocyte immunoglobulin like receptor subfamily B1 (LILRB1) is considered to be an immunosuppressive molecule, which is an important receptor of human leukocyte antigen G. However, the clinical significanc...

Full description

Bibliographic Details
Main Authors: Yawei Zhang, Han Wang, Xiaoyu Xu, Huifang Liu, Tengfei Hao, Songcheng Yin, Changhua Zhang, Yulong He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
gastric cancer
LILRB1
tumor-associated macrophages
prognosis
tumor immune microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.668707/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.668707/full

Similar Items